13F-HR filed by TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 51 holding rows worth $1,968,963,283.
- Accession
- 0001214659-26-006493
- Filer
- CIK 1232621
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 51 entries on the cover page, a total value of $1,968,963,283 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,968,963,283 with VALUE read as dollars as filed, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTANG KEVIN028-14818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 12,229,500 | $181,241,190 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,050,000 | $119,847,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,236,027 | $114,184,174 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 3,785,991 | $113,579,730 | dollars as filed | |
| SPY | 78462F103 | SHS | 168,000 | $109,257,120 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 2,259,889 | $108,813,655 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 3,399,900 | $103,356,960 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,500,000 | $102,195,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,892,200 | $95,442,568 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 4,573,530 | $92,065,159 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 16,790,809 | $88,823,380 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,188,624 | $83,381,974 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 2,649,368 | $79,878,445 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,330,879 | $73,810,549 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 1,500,000 | $60,465,000 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 707,500 | $54,406,750 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 260,000 | $42,515,200 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 470,000 | $41,773,600 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,792,626 | $35,063,765 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 4,814,700 | $25,903,086 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 6,417,500 | $24,835,725 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 264,692 | $22,212,953 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 4,002,200 | $22,132,166 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,160,000 | $21,309,200 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 500,000 | $16,280,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 500,000 | $16,270,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 450,000 | $14,994,000 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,149,557 | $13,511,600 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 6,143,132 | $7,740,346 | dollars as filed | |
| JOURNEY MED CORP | 48115J109 | COM | 1,610,000 | $7,550,900 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 500,000 | $6,950,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 35,000 | $6,416,550 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 350,000 | $6,293,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 538,658 | $5,709,775 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 4,245,085 | $5,263,905 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 100,000 | $5,080,000 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,250,000 | $5,000,625 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L209 | COM NEW | 664,314 | $4,929,210 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 600,000 | $4,350,000 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 451,114 | $4,127,696 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 100,000 | $3,383,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 200,000 | $3,236,000 | dollars as filed | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,886,748 | $3,188,604 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,480,823 | $3,124,537 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 666,022 | $2,051,348 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 483,021 | $1,985,216 | dollars as filed | |
| ABEONA THERAPEUTICS INC | 00289Y206 | COM NEW | 400,000 | $1,792,000 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,167,773 | $1,401,328 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 439,878 | $857,762 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 399,700 | $623,532 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 100,000 | $358,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-006493 | this filing | 2026-05-15 | acceptance time not in the bulk data set |